Plain-English translation of NCT07814664 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
China
Sponsor
Chinese SLE Treatment And Research Group
Enrollment target
~294 participants
Started
October 2026
Primary completion
March 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mengtao Li
Chinese SLE Treatment And Research Group
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.